Unitaid Call for Proposals: Improving access to lifesaving tools for prevention, diagnosis, and management of pre-eclampsia and maternal anemia
Unitaid is pleased to announce the Call for Proposals: “Improving access to lifesaving tools for prevention, diagnosis, and management of pre-eclampsia and maternal anemia”, aimed at accelerating uptake and strengthening the market for new and underused products and delivery strategies for pre-eclampsia and maternal anemia.
In response to this clear need, and the opportunities for accelerating progress – Unitaid is launching two calls for proposals. Proponents may apply to one or both. If applying to both, then two separate proposals are required.
Call for Proposals 1: Accelerate demand and adoption of new and underused tools through optimized and locally tailored models of care for pre-eclampsia and maternal anemia.
- Goal: to accelerate uptake and consistent use of available, underutilized tools to address PE and anemia in high-burden LMICs through large scale, multi-country demonstration projects with robust evidence generation to inform broader uptake. Projects should aim to catalyze a pathway to product adoption at national scale in intervention countries by the end of the project period.
- Unitaid is seeking a project from a consortium that is led by a South-based implementer – i.e. an organization that is headquartered in a low-or middle-income country.
- The approximate funding allocation for work outlined in Call for Proposals #1 is expected to be up to US$ 25 million – with a balanced emphasis on PE- and anemia-focused activities
Call for Proposals 2: Supply-side activities to support equitable access to pre-eclampsia and anemia products.
- Goal: to advance targeted product development, market access or other supply-side activities for a distinct subset of products described below. Access strategies for priority products should consider factors such as quality assurance, affordability, registration, regulatory approvals, sufficient supply, supply logistics management, and climate resilience considerations.
- For Call for Proposals #2, the approximate funding allocation is expected to be up to US$25 million, with the expected allocation per area outlined below. Proponents can apply to one or all outlined areas, with a preference for proposals including a consortium capable of comprehensively covering all areas.
- Support product development, validation, and introduction of new and highly affordable point-of-care biomarker-based diagnostics for PE (indicative budget: up to US$ 8m).
- Support validation of the digital blood pressure measurement tools and implementation research on their introduction for self-monitoring in pregnancy (indicative budget: up to US$4m).
- Establish anemia diagnostic landscape and direction through market coordination (indicative budget: up to US$4m).
- Targeted supply-side activities for available PE products (indicative budget: up to $6m)
- Targeted supply-side activities to strengthen the market for modern IV iron (indicative budget: up to US$3m).
Read here for more information.
Application deadline, 12th of February, 2025, at 12:00 (noon) CET.
